ARTICLE | Clinical News
GKT137831: Phase II data
September 21, 2015 7:00 AM UTC
Top-line data from a double-blind, international Phase II trial in 155 Type II diabetics with diabetic nephropathy showed that twice-daily 100 mg oral GKT137831 for 6 weeks followed by a twice-daily 2...